A detailed history of Ubs Asset Management Americas Inc transactions in Nevro Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 1,000,000 shares of NVRO stock, worth $3.79 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,000,000
Previous 433,538 130.66%
Holding current value
$3.79 Million
Previous $3.65 Million 52.88%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.71 - $10.1 $2.67 Million - $5.72 Million
566,462 Added 130.66%
1,000,000 $5.58 Million
Q2 2024

Aug 13, 2024

BUY
$7.96 - $13.59 $3.14 Million - $5.36 Million
394,577 Added 1012.75%
433,538 $3.65 Million
Q3 2023

Nov 13, 2023

BUY
$18.22 - $25.85 $41,231 - $58,498
2,263 Added 6.17%
38,961 $748,000
Q4 2022

Feb 14, 2023

BUY
$36.43 - $49.4 $72,094 - $97,762
1,979 Added 5.7%
36,698 $1.45 Million
Q3 2022

Nov 14, 2022

SELL
$40.66 - $53.03 $354,839 - $462,792
-8,727 Reduced 20.09%
34,719 $1.62 Million
Q2 2022

Aug 12, 2022

SELL
$40.85 - $77.67 $42,238 - $80,310
-1,034 Reduced 2.32%
43,446 $1.9 Million
Q1 2022

May 16, 2022

BUY
$59.95 - $92.06 $400,226 - $614,592
6,676 Added 17.66%
44,480 $3.22 Million
Q4 2021

Feb 14, 2022

BUY
$81.07 - $121.29 $28,293 - $42,330
349 Added 0.93%
37,804 $3.06 Million
Q3 2021

Nov 15, 2021

SELL
$101.99 - $166.36 $47,629 - $77,690
-467 Reduced 1.23%
37,455 $4.36 Million
Q2 2021

Aug 16, 2021

BUY
$141.6 - $179.06 $46,303 - $58,552
327 Added 0.87%
37,922 $6.29 Million
Q1 2021

May 14, 2021

BUY
$132.81 - $182.18 $41,436 - $56,840
312 Added 0.84%
37,595 $5.24 Million
Q4 2020

Mar 01, 2021

BUY
$138.17 - $184.34 $241,797 - $322,595
1,750 Added 4.92%
37,283 $6.45 Million
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $121,391 - $154,822
1,064 Added 3.09%
35,533 $4.95 Million
Q2 2020

Aug 14, 2020

SELL
$89.45 - $129.85 $113,243 - $164,390
-1,266 Reduced 3.54%
34,469 $4.12 Million
Q1 2020

May 15, 2020

BUY
$70.23 - $144.31 $136,456 - $280,394
1,943 Added 5.75%
35,735 $3.57 Million
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $9,551 - $14,692
125 Added 0.37%
33,792 $3.97 Million
Q3 2019

Nov 14, 2019

BUY
$61.52 - $91.1 $422,457 - $625,583
6,867 Added 25.62%
33,667 $2.89 Million
Q2 2019

Aug 15, 2019

BUY
$58.04 - $66.99 $367,161 - $423,778
6,326 Added 30.9%
26,800 $0
Q1 2019

May 14, 2019

BUY
$35.52 - $62.62 $372,036 - $655,881
10,474 Added 104.74%
20,474 $0
Q4 2018

Feb 13, 2019

SELL
$35.43 - $56.29 $320,110 - $508,580
-9,035 Reduced 47.47%
10,000 $388,000
Q3 2018

Nov 14, 2018

BUY
$44.22 - $75.47 $24,099 - $41,131
545 Added 2.95%
19,035 $0
Q2 2018

Aug 14, 2018

BUY
$72.38 - $92.5 $72,814 - $93,055
1,006 Added 5.75%
18,490 $0
Q1 2018

May 14, 2018

BUY
$69.46 - $88.57 $173,233 - $220,893
2,494 Added 16.64%
17,484 $0
Q4 2017

Feb 09, 2018

SELL
$65.94 - $93.31 $54,664 - $77,353
-829 Reduced 5.24%
14,990 $0
Q3 2017

Nov 13, 2017

BUY
$80.87 - $91.08 $1.28 Million - $1.44 Million
15,819
15,819 $0

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $134M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.